PTEN ablation in RasHa/Fos skin carcinogenesis invokes p53-dependent p21 to delay conversion while p53-independent p21 limits progression via cyclin D1/E2 inhibition-Reference-Cited by-同舟云学术

PTEN ablation in RasHa/Fos skin carcinogenesis invokes p53-dependent p21 to delay conversion while p53-independent p21 limits progression via cyclin D1/E2 inhibition

Published:2013-09-16 Issue:32 Volume:33 Page:4132-4143
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Macdonald F H,Yao D,Quinn J A,Greenhalgh D A

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2013372.pdf

Reference52 articles.

1. Hanahan D, Weinberg RA . Hallmarks of cancer: the next generation. Cell 2011; 144: 646–674.

2. Floor SL, Dumont JE, Maenhaut C, Raspe E . Hallmarks of cancer: of all cancer cells, all the time? Trends Mol Med 2012; 18: 509–515.

3. Sprouffske K, Pepper JW, Maley CC . Accurate reconstruction of the temporal order of mutations in neoplastic progression. Cancer Prev Res 2011; 4: 1135–1144.

4. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumourigenesis. Nature 2005; 436: 725–730.

5. Leong W, Chau JF, Li B . p53 deficiency leads to compensatory up-regulation of p16INK4a. Mol Cancer Res 2009; 7: 354–360.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 14‐3‐3σ/Stratifin and p21 limit AKT‐related malignant progression in skin carcinogenesis following MDM2‐associated p53 loss;Molecular Carcinogenesis;2024-06-13

2. Multistage Carcinogenesis: Cell and Animal Models;Reference Module in Biomedical Sciences;2024

3. Mechanisms of cancer stem cell senescence: Current understanding and future perspectives;Clinical and Experimental Pharmacology and Physiology;2021-06-23

4. Epidermal ROCK2 induces AKT1/GSK3β/β-catenin, NFκB and dermal tenascin C; but enhanced differentiation and p53/p21 inhibit papilloma;Carcinogenesis;2020-01-07

5. Discovery of Potent and Selective MRCK Inhibitors with Therapeutic Effect on Skin Cancer;Cancer Research;2018-01-30